Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Cipla
UBS
Fuji
Farmers Insurance
Julphar
Dow
Moodys
Express Scripts
QuintilesIMS

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021494

« Back to Dashboard

NDA 021494 describes AXID, which is a drug marketed by Smithkline Beecham, Braintree, and Pfizer, and is included in three NDAs. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the AXID profile page.

The generic ingredient in AXID is nizatidine. There are seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nizatidine profile page.
Summary for 021494
Tradename:AXID
Applicant:Braintree
Ingredient:nizatidine
Patents:1
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021494

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;ORALStrength15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:May 25, 2004TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Jul 17, 2022Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Harvard Business School
Covington
Dow
Moodys
Colorcon
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot